Usana Health Sciences Profit Margin

The latest profit margin for USNA is -2.43% as of June 2026. That compares with 3.8% in the prior-year period — down 163.9% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Usana Health Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, USNA's profit margin moved from 3.8% to -2.43% — a 163.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Usana Health Sciences's valuation or profitability profile.

Against Healthcare companies, USNA currently prints -2.43% for profit margin, while the sector average sits near 13.89%. That is roughly 117.5% below the sector mean. Large gaps often invite a closer look at Usana Health Sciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Usana Health Sciences converts resources into returns. At -2.43%, USNA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 3.8% in the prior-year period — down 163.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting USNA's profit margin (-2.43%), review year-over-year change from 3.8%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.